A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Monday 28 January 2013

Isoxadifen: here's the original reference

Following our earlier post this morning, it is with great thanks to Justizhauptsekretärin Elke Höchner of the German Bundespatentgericht that The SPC Blog is delighted to be able to offer readers the full text of the decision -- in German -- in which the status of safeners was referred to the Court of Justice of the European Union for a preliminary ruling in Case C-11/13 Bayer CropScience. You can read it here.

No comments: